Publication

Date Item Type Full Text Status

9 September 2025

Physician self-reported factors driving clinical decision-making in management of patients with T2D and ASCVD/high risk of ASCVD across the middle East and Africa: a cross-sectional study. (2025) Sam Salek, Hani Sabbour, Naji Alamuddin, Fatheya Alawadi, Hessa Alkandari, Wael Almahmeed, Samir H. Assaad-Khalil, Emel Mashaki Ceyhan, Jihad Haddad, Landman Lombard, Mary Ngome, Rayaz A. Malik and Gourav Yadav

10 June 2024

Editorial: Exploring neuroinflammatory pathways that contribute to chronic pain, volume II. (2024) Lisa A. Lione and Amy Fisher

7 November 2023

Editorial: The use of plant metabolites to ameliorate sequelae of chemotherapy. (2023) Cijo George Vazhappilly, Shoib Sarwar Siddiqui, Ruby John Anto, Rajan Radhakrishnan and Naveen Kumar Devanga Ragupathi

13 June 2023

Identification of cardiotoxicity related to non-small cell lung cancer (NSCLC) treatments: A systematic review. (2023) Stefanie Ho Yi Chan, Yasmin Khatib, Sherael Webley, Deborah Layton and Sam Salek

9 May 2023

Assessment of the effectiveness and efficiency of the economic community of West African States Medicines Regulatory Harmonization initiative by the pharmaceutical industry. (2023) Mercy Owusu-Asante, Delese Mimi Darko, Stuart Walker and Sam Salek

25 November 2022

Assessment of the effectiveness and efficiency of the West Africa medicines regulatory harmonization initiative by the member countries. (2022) Mercy Owusu-Asante, Delese Mimi Darko, Stuart Walker and Sam Salek

3 November 2022

Evaluation of the effectiveness and efficiency of the East African community joint assessment procedure by pharmaceutical companies: Opportunities for improvement. (2022) Nancy Ngum, Jane Mashingia, Margareth Ndomondo-Sigonda, Stuart Walker and Sam Salek

15 September 2022

Editorial: Exploring neuroinflammatory pathways that contribute to chronic pain. (2022) Lisa A. Lione and Amy Fisher

5 July 2022

Evaluation of the Effectiveness and Efficiency of the East African Community Joint Assessment Procedure by Member Countries: The Way Forward. (2022) Nancy Ngum, Jane Mashingia, Margareth Ndomondo-Sigonda, Stuart Walker and Sam Salek

9 August 2021

Comparison of BRICS-TM Countries' Biosimilar Regulatory Frameworks With Australia, Canada and Switzerland: Benchmarking Best Practices. (2021) Hasumati Rahalkar, Alan Sheppard and Sam Salek

23 July 2021

South African Regulatory Authority: The Impact of Reliance on the Review Process Leading to Improved Patient Access. (2021) Andrea Keyter, Sam Salek, Lorraine Danks, Portia Nkambule, Boitumelo Semete-Makokotlela and Stuart Walker

8 February 2021

Preclinical Neuropathic Pain Assessment; the Importance of Translatability and Bidirectional Research : Translatable and Bidirectional Research. (2021) Amy Fisher, Michael Lanigan, Neil Upton and Lisa Lione picture_as_pdf

5 March 2020

Development of a Novel Hematological Malignancy Specific Patient-Reported Outcome Measure (HM-PRO) : Content Validity. (2020) Pushpendra Goswami, Esther Oliva, Tatyana Ionova, R Else, J Kell, AK Fielding, DM Jennings, M Karakantza, S Al-Ismail, GP Collins, S McConnell, Catherine Langton and Sam Salek

29 March 2019

Factors influencing delays in patient access to new medicines in Canada: a retrospective study of reimbursement processes in public drug plans. (2019) Mir-Saeed Shayegan Salek, Sarah Lussier Hoskyn, Jeffrey Johns, Nicola Allen and Chander Sehgal

14 March 2019

The South African Medicines Control Council: Comparison of Its Registration Process With Australia, Canada, Singapore, and Switzerland. (2019) Andrea Keyter, Mir-Saeed Shayegan Salek, Shabir Banoo and Stuart R. Walker

18 February 2019

Pan-Canadian Pharmaceutical Alliance (pCPA): Timelines Analysis and Policy Implications. (2019) Mir-Saeed Shayegan Salek, Sarah Lussier Hoskyn, Jeffrey Johns, Nicola Allen and Chander Sehgal

1 February 2019

Assessing the 2004-2018 fentanyl misusing issues reported to an international range of adverse reporting systems. (2019) Fabrizio Schifano, Stephania Chiappini, John Corkery and Amira Guirguis picture_as_pdf

4 December 2018

The South African Regulatory System: Past, Present, and Future. (2018) A Keyter, Shabir Banoo, Mir-Saeed Shayegan Salek and Stuart R. Walker

27 November 2018

Cost-Utility Analysis of Venous Thromboembolism Prophylaxis Strategies for People Undergoing Elective Total Hip and Total Knee Replacement Surgeries in the English National Health Service. (2018) Dalia M Dawoud, David Wonderling, Jessica Glen, Sedina Lewis, Xavier Griffin, Beverley J Hunt, Gerard Stansby, Michael Reed, Nigel Rossiter, Jagjot Chahal, Carlos Sharpin and Peter Barry

28 September 2018

Quality, Non-clinical and Clinical Considerations for Biosimilar Monoclonal Antibody Development: EU, WHO, USA, Canada, and BRICS-TM Regulatory Guidelines. (2018) Hasumati Rahalkar, Hacer Coskun Cetintas and Mir-Saeed Shayegan Salek

13 August 2018

Cannabidiol (CBD) is a novel inhibitor for exosome and microvesicle (EMV) release in cancer. (2018) Uchini S Kosgodage, Rhys Mould, Aine Henley, alistair Nunn, Geoffrey Guy, E. Louise Thomas, Jameel Inal, Jimmy Bell and Sigrun Lange

21 March 2018

Is there a potential of misuse for venlafaxine and bupropion? (2018) Fabrizio Schifano and Stephania Chiappini description

30 June 2017

A comparison of reimbursement recommendations by European HTA agencies : Is there opportunity for further alignment? (2017) Nicola Allen, Lawrence Liberti, Stuart R. Walker and Sam Salek

10 April 2017

Evaluating Quality of Decision-Making Processes in Medicines' Development, Regulatory Review, and Health Technology Assessment : A Systematic Review of the Literature. (2017) M Bujar, N McAuslane, S Walker and Mir-Saeed Shayegan Salek

13 July 2016

The Development and Validation of a Generic Instrument, QoDoS, for Assessing the Quality of Decision Making. (2016) R Donelan, Stuart Walker and Mir-Saeed Shayegan Salek

11 June 2015

A practical approach to communicating benefit-risk decisions of medicines to stakeholders. (2015) J Leong, S Walker and Mir-Saeed Shayegan Salek